Overview

Psoriatic Oligoarthritis Intervention With Symptomatic thErapy

Status:
Completed
Trial end date:
2020-07-16
Target enrollment:
Participant gender:
Summary
POISE is a two arm interventional trial nested within a cohort (Trials Within Cohorts or TWiCs design). This tests less aggressive early therapy in patients newly diagnosed with low impact oligoarticular PsA. Arm 1 will receive standard step up therapy in the cohort and act as the control group. Arm 2 will receive local steroid injections to active joints and will be able to use non-steroidal anti-inflammatory drugs (NSAIDs) only
Phase:
Phase 4
Details
Lead Sponsor:
University of Oxford
Collaborator:
National Institute for Health Research, United Kingdom
Treatments:
Leflunomide
Methotrexate
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Sulfasalazine
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide